Financials

  • Market Capitalization 1.8325 B
  • Employee 49
  • Founded 2024
  • CEO N/A
  • Website www.braveheart.bio
  • Headquarter Delaware, United States
  • FIGI BBG01YCFNLC2
  • Industry N/A

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
1983
ALMR
Alamar Biosciences, Inc. Common Stock
26.48 USD-7.67%-13.01%-14.58%+17.17%1.84 B USD
1985
COAG
Hemab Therapeutics Holdings, Inc. Common Stock
39.29 USD-1.43%-5.33%+11.62%+45.52%1.84 B USD
2022
TRAX
First Tracks Biotherapeutics, Inc. Ordinary Shares
41.64 USD-6.34%-10.49%-1.49%+103.02%1.75 B USD
2042
KRSA
Korsana Biosciences, Inc. Common Stock
37.56 USD+5.95%+18.11%+17.38%+53.81%1.71 B USD

Frequently asked questions about Braveheart Bio, Inc. Common Stock

What is the Braveheart Bio, Inc. Common Stock stock price today?

The current price of Braveheart Bio, Inc. Common Stock (BRVE) is 20.3900. Over the past 24 hours, the stock has changed by +5.81%. Follow the BRVE chart for real-time price dynamics.

What is the stock ticker of Braveheart Bio, Inc. Common Stock?

Braveheart Bio, Inc. Common Stock trades under the ticker BRVE. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is Braveheart Bio, Inc. Common Stock stock going up?

BRVE has changed by +1.75% over the last week, -3.55% over the last month, and -32.48% over the last year. Review the chart to see whether the current move is part of a broader trend.

What is the market capitalization of Braveheart Bio, Inc. Common Stock?

Braveheart Bio, Inc. Common Stock currently has a market capitalization of 1.83 B. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.

What were Braveheart Bio, Inc. Common Stock earnings last quarter?

Last quarter, Braveheart Bio, Inc. Common Stock reported earnings of -0.51 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.

What was Braveheart Bio, Inc. Common Stock net income for the last quarter?

Braveheart Bio, Inc. Common Stock reported net income of 26.5 M for the last quarter. The previous quarter showed -14.99 M, which means net income changed by +276.77%.

How many employees does Braveheart Bio, Inc. Common Stock have?

As of the latest available data, Braveheart Bio, Inc. Common Stock has 49 employees. Workforce size can provide additional context about the company's scale and operations.

How can I buy Braveheart Bio, Inc. Common Stock stock?

You can buy Braveheart Bio, Inc. Common Stock (BRVE) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in Braveheart Bio, Inc. Common Stock stock?

Investing in Braveheart Bio, Inc. Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the BRVE chart and related analysis on metatrader.com as part of your research.